{{Drugbox
| IUPAC_name = ''N''-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1''H''-indazole-3-carboxamide
| image = 5F-ADB-PINACA_structure.png

<!--Clinical data-->
| tradename =  
| pregnancy_AU = 
| pregnancy_US = 
| pregnancy_category =  
| legal_AU = 
| legal_CA = Schedule II
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = 
| CAS_number = 1863065-90-0
| ATC_prefix =  
| ATC_suffix =  
| PubChem = 119058050
| ChemSpiderID      = 52085408
| UNII = LOL2KQM530

<!--Chemical data-->
| C=19 | H=27 | N=4 | O=2 | F=1
| smiles            = CC(C)(C)[C@@H](C(=O)N)NC(=O)c1c2ccccc2n(n1)CCCCCF
| StdInChI          = 1S/C19H27FN4O2/c1-19(2,3)16(17(21)25)22-18(26)15-13-9-5-6-10-14(13)24(23-15)12-8-4-7-11-20/h5-6,9-10,16H,4,7-8,11-12H2,1-3H3,(H2,21,25)(H,22,26)/t16-/m1/s1
| StdInChIKey       = SOYDDJYBRCNNIT-MRXNPFEDSA-N
| molecular_weight = 362.5 g/mol
}}

'''5F-ADB-PINACA''' is a [[cannabinoid]] [[designer drug]] that is an ingredient in some [[synthetic cannabis]] products. It is a potent [[agonist]] of the [[CB1 receptor|CB<sub>1</sub> receptor]] and [[CB2 receptor|CB<sub>2</sub> receptor]] with [[EC50|EC<sub>50</sub>]] values of 0.24&nbsp;nM and 2.1&nbsp;nM respectively.<ref>{{cite journal | url=http://pubs.acs.org/doi/abs/10.1021/acschemneuro.5b00112 | title=The pharmacology of indole and indazole synthetic cannabinoid designer drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA and 5F-ADBICA | author=Samuel D Banister | author2=Michael Moir | author3=Jordyn Stuart| author4=Richard C Kevin | author5=Katie E Wood| author6=Mitchell Longworth | author7=Shane M Wilkinson| author8=Corinne Beinat | author9=Alxendra S Buchanan| author10=Michelle Glass | author11=Mark Connor| author12=Iain S McGregor | author13=Michael Kassiou | journal=ACS Chemical Neuroscience |date=July 2015  | doi=10.1021/acschemneuro.5b00112 | pmid=26134475 | volume=6 | pages=1546â€“59}}</ref><ref>{{cite web | url = https://www.caymanchem.com/app/template/Product.vm/catalog/14764 | title = 5F-ADB-PINACA | publisher = Cayman Chemical}}</ref>

==Legality==

5F-ADB-PINACA is listed in the Fifth Schedule of the Misuse of Drugs Act (MDA) and therefore illegal in Singapore as of May 2015.<ref>{{cite web | url=http://www.cnb.gov.sg/Libraries/CNB_Newsroom_Files/CNB_NR_-_30_Apr_2015.sflb.ashx | title=CNB NEWS RELEASE | publisher=Central Narcotics Bureau (CNB) | date=30 April 2015 | accessdate=24 July 2015}}</ref>

==See also==
{{div col|colwidth=30em}}
* [[5F-AB-PINACA]]
* [[5F-ADB]]
* [[5F-AMB]]
* [[5F-APINACA]]
* [[AB-FUBINACA]]
* [[AB-CHFUPYCA]]
* [[AB-CHMINACA]]
* [[AB-PINACA]]
* [[ADB-CHMINACA]]
* [[ADB-FUBINACA]]
* [[ADB-PINACA]]
* [[ADBICA]]
* [[APICA]]
* [[APINACA]]
* [[APP-FUBINACA]]
* [[MDMB-CHMICA]]
* [[MDMB-CHMINACA]]
* [[MDMB-FUBINACA]]
* [[PX-1]]
* [[PX-2]]
* [[PX-3]]
{{Div col end}}

==References==
{{reflist}}

{{Cannabinoids}}

[[Category:Cannabinoids]]
[[Category:Designer drugs]]
[[Category:Indazoles]]
[[Category:Indazolecarboxamides]]
[[Category:Fluoroarenes]]


{{cannabinoid-stub}}